Axsome Therapeutics Inc (AXSM)

44.15
-2.52(-5.40%)
Pre Market
44.55
+0.40(+0.91%)
- Real-time Data
  • Volume:
    961,256
  • Day's Range:
    43.97 - 47.59
  • 52 wk Range:
    20.63 - 71.98

AXSM Analysis

Prev. Close
46.67
Day's Range
43.97-47.59
Revenue
8.82M
Open
47
52 wk Range
20.63-71.98
EPS
-3.92
Volume
961,256
Market Cap
1.89B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,526,978
P/E Ratio
-11.79
Beta
1.92
1-Year Change
29.21%
Shares Outstanding
42,878,002
Next Earnings Date
Nov 10, 2022
What is your sentiment on Axsome Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Axsome Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Axsome Therapeutics Inc Analysis

Axsome Therapeutics Inc Company Profile

Axsome Therapeutics Inc Company Profile

Employees
108

Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is developing novel therapies for central nervous system (CNS) disorders for which there are limited treatment options. It is developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. The Company's CNS portfolio includes four product candidates, such as AXS-05, AXS-07, AXS-12, and AXS-14. AXS-05 is being developed for the treatment of major depressive disorder (MDD), Alzheimer's disease agitation (AD agitation), and smoking cessation. AXS-07 is a novel, oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine. AXS-12 is an investigational medicine in development for the treatment of narcolepsy. The Company also provides Sunosi, which is dual-acting dopamine and norepinephrine reuptake inhibitor indicated to improve wakefulness in adult patients.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellBuy
  • Offering soon?
    0
    • Sidus Space Signs MOU with Exo-Space to Support Edge Computing Technology
      0
      • Advise to buy more ??!!
        0
        • OPA??
          0
          • FDA positive news?
            0
            • What
              0
              • Slowly
                0
                • Time to buy today
                  1
                  • Will bounce 20% tomorrow
                    3
                    • 27.9 9/aug
                      0